Therapeutic Group: Contraceptive Presentation POP-D : Each tablet contains 0.075 mg Desogestrel. Description POP-D is a progestogen-only tablet, which contains the progestogen Desogestrel. Like other progestogen-only tablets, POP-D is best suited for use during breast feeding and for women who may not or do not want to use estrogens. In contrast to traditional progestogen-only tablets, […]
Therapeutic Group: Anti Histamine Presentation Neocilor tablet: Each film-coated tablet contains Desloratadine INN 5 mg. Neocilor syrup: Each 5 ml syrup contains Desloratadine INN 2.5 mg. Description Neocilor is a preparation of Desloratadine. Desloratadine is a long-acting tricyclic histamine antagonist with selective H1-receptor antagonist activity. It is a non-sedating antihistamine. Desloratadine has effects on the […]
Therapeutic Group: Monoclonal Antibody Presentation Denosis 120: Each ml solution for injection contains Denosumab 70 mg. Description Denosumab is a human IgG2 monoclonal antibody with affinity and specificity for human RANKL (receptor activator of nuclear factor kappa-B ligand). Denosumab binds to RANKL, a transmembrane or soluble protein essential for the formation, function, and survival of […]
Therapeutic Group: Monoclonal Antibody Presentation Denosis 60: Each pre-filled syringe contains 1 ml sterile solution of Denosumab 60 mg. Description Denosumab is a human IgG2 monoclonal antibody with affinity and specificity for human RANKL (receptor activator of nuclear factor kappa-B ligand). Denosumab binds to RANKL, a transmembrane or soluble protein essential for the formation, function, […]
Therapeutic Group: Antibiotic Presentation Delameg IV Infusion: Each vial contains Delafloxacin Meglumine INN equivalent to Delafloxacin 300 mg as lyophilized cake or powder. Description Delafloxacin is a fourth generation Fluoroquinolone with expanded activity against Gram positive bacteria including multidrug resistant strains of Streptococcus pneumoniae & Staphylococcus aureus (MRSA), as well as atypical pathogens. Like other […]
Therapeutic Group: Analgesic, Anti Inflammatory Presentation Deflazit 6 Tablet: Each tablet contains Deflazacort INN 6 mg. Deflazit 24 Tablet: Each tablet contains Deflazacort INN 24 mg Deflazit 50 ml Suspension: Each 5 ml Suspension contains Deflazacort INN 6 mg Deflazit 18 Tablet: Each tablet contains Deflazacort INN 18 mg. Description Deflazacort is an oxazoline derivative […]
Therapeutic Group: Kinase inhibitor Presentation Dasacentâ„¢ 50: Each film coated tablet contains Dasatinib monohydrate INN eqv. to Dasatinib 50 mg. Dasacentâ„¢ 100: Each film coated tablet contains Dasatinib monohydrate INN eqv. to Dasatinib 100 mg. Dasacentâ„¢ 140: Each film coated tablet contains Dasatinib monohydrate INN eqv. to Dasatinib 140 mg Description Dasatinib, at nanomolar concentrations, […]
Therapeutic Group: Drugs for Hematological Disorder Presentation Embardia 25 mcg Injection: Each pre-filled syringe contains Darbepoetin alfa INN 25 mcg in 0.42 ml solution for injection. Embardia 40 mcg Injection: Each pre-filled syringe contains Darbepoetin alfa INN 40 mcg in 0.40 ml solution for injection. Embardia 60 mcg Injection: Each pre-filled syringe contains Darbepoetin alfa […]
Therapeutic Group: Urological Presentation Maturex 30 Tablet: Each tablet contains Dapoxetine Hydrochloride INN equivalent to Dapoxetine 30 mg. Maturex 60 Tablet: Each tablet contains Dapoxetine Hydrochloride INN equivalent to Dapoxetine 60 mg. Description Dapoxetine tablet belongs to the pharmacotherapeutic group of Selective Serotonin Reuptake Inhibitors (SSRIs). The mechanism of action of dapoxetine in premature ejaculation […]
Therapeutic Group: Sodium-glucose Co-transporter 2 inhibitor Presentation Dapaglip TM 5: Each tablet contains Dapagliflozin Propanediol Monohydrate INN equivalent to Dapagliflozin 5 mg. Dapaglip TM 10: Each tablet contains Dapagliflozin Propanediol Monohydrate INN equivalent to Dapagliflozin 10 mg. Description Dapagliflozin is an inhibitor of Sodium-Glucose Cotransporter 2 (SGLT2). By inhibiting SGLT2, Dapagliflozin reduces reabsorption of filtered […]